Japan Production Value by Application and Therapeutic Category: Yearly

Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data was reported at 12,736,697.000 JPY th in 2020. This records a decrease from the previous number of 12,886,221.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data is updated yearly, averaging 12,811,459.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 12,886,221.000 JPY th in 2019 and a record low of 12,736,697.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
12,736,697.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use

Production Value: Require guidance or OTC Drug: Allergy Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Allergy Drug data was reported at 8,795,993.000 JPY th in 2020. This records a decrease from the previous number of 11,344,072.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Allergy Drug data is updated yearly, averaging 10,070,032.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 11,344,072.000 JPY th in 2019 and a record low of 8,795,993.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Allergy Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
8,795,993.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Allergy Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Allergy Drug

Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data was reported at 17,316.000 JPY th in 2020. This records a decrease from the previous number of 36,709.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data is updated yearly, averaging 27,012.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 36,709.000 JPY th in 2019 and a record low of 17,316.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
17,316.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug

Production Value: Require guidance or OTC Drug: Cardiovascular Preparation

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data was reported at 9,176,715.000 JPY th in 2020. This records a decrease from the previous number of 12,569,978.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data is updated yearly, averaging 10,873,346.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 12,569,978.000 JPY th in 2019 and a record low of 9,176,715.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
9,176,715.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Cardiovascular Preparation from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Cardiovascular Preparation

Production Value: Require guidance or OTC Drug: Cell Activation Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Cell Activation Drug data was reported at 1,141,676.000 JPY th in 2020. This records a decrease from the previous number of 1,229,953.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Cell Activation Drug data is updated yearly, averaging 1,185,814.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 1,229,953.000 JPY th in 2019 and a record low of 1,141,676.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Cell Activation Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
1,141,676.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Cell Activation Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Cell Activation Drug

Production Value: Require guidance or OTC Drug: Central Nervous System Agent

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Central Nervous System Agent data was reported at 143,508,110.000 JPY th in 2020. This records an increase from the previous number of 139,498,348.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Central Nervous System Agent data is updated yearly, averaging 141,503,229.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 143,508,110.000 JPY th in 2020 and a record low of 139,498,348.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Central Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
143,508,110.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Central Nervous System Agent from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Central Nervous System Agent

Production Value: Require guidance or OTC Drug: Chemotherapeutics

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Chemotherapeutics data was reported at 420,638.000 JPY th in 2020. This records a decrease from the previous number of 537,251.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Chemotherapeutics data is updated yearly, averaging 478,944.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 537,251.000 JPY th in 2019 and a record low of 420,638.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Chemotherapeutics data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
420,638.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Chemotherapeutics from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Chemotherapeutics

Production Value: Require guidance or OTC Drug: Crude Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Crude Drug data was reported at 1,362,992.000 JPY th in 2020. This records a decrease from the previous number of 3,432,367.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Crude Drug data is updated yearly, averaging 2,397,679.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 3,432,367.000 JPY th in 2019 and a record low of 1,362,992.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Crude Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
1,362,992.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Crude Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Crude Drug

Production Value: Require guidance or OTC Drug: Dermatological Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Dermatological Drug data was reported at 175,795,236.000 JPY th in 2020. This records a decrease from the previous number of 178,165,769.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Dermatological Drug data is updated yearly, averaging 176,980,502.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 178,165,769.000 JPY th in 2019 and a record low of 175,795,236.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Dermatological Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
175,795,236.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Dermatological Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Dermatological Drug

Production Value: Require guidance or OTC Drug: Digestive Organ Agent

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Digestive Organ Agent data was reported at 75,292,367.000 JPY th in 2020. This records a decrease from the previous number of 79,152,039.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Digestive Organ Agent data is updated yearly, averaging 77,222,203.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 79,152,039.000 JPY th in 2019 and a record low of 75,292,367.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Digestive Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
75,292,367.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Digestive Organ Agent from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Digestive Organ Agent

Production Value: Require guidance or OTC Drug: Dispensing Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Dispensing Drug data was reported at 2,657,033.000 JPY th in 2020. This records an increase from the previous number of 2,420,189.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Dispensing Drug data is updated yearly, averaging 2,538,611.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 2,657,033.000 JPY th in 2020 and a record low of 2,420,189.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Dispensing Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
2,657,033.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Dispensing Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Dispensing Drug

Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data was reported at 9,188,581.000 JPY th in 2020. This records a decrease from the previous number of 9,623,661.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data is updated yearly, averaging 9,406,121.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 9,623,661.000 JPY th in 2019 and a record low of 9,188,581.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
9,188,581.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription

Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data was reported at 3,354,223.000 JPY th in 2020. This records a decrease from the previous number of 3,418,047.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data is updated yearly, averaging 3,386,135.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 3,418,047.000 JPY th in 2019 and a record low of 3,354,223.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
3,354,223.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic

Production Value: Require guidance or OTC Drug: Hormones, include Antihormones

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data was reported at 538,684.000 JPY th in 2020. This records an increase from the previous number of 387,415.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data is updated yearly, averaging 463,049.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 538,684.000 JPY th in 2020 and a record low of 387,415.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
538,684.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Hormones, include Antihormones from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Hormones, include Antihormones

Production Value: Require guidance or OTC Drug: Nourishing Tonic

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Nourishing Tonic data was reported at 47,328,911.000 JPY th in 2020. This records an increase from the previous number of 46,576,861.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Nourishing Tonic data is updated yearly, averaging 46,952,886.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 47,328,911.000 JPY th in 2020 and a record low of 46,576,861.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Nourishing Tonic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
47,328,911.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Nourishing Tonic from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Nourishing Tonic

Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data was reported at 6,869.000 JPY th in 2020. This records an increase from the previous number of 3,337.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data is updated yearly, averaging 5,103.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 6,869.000 JPY th in 2020 and a record low of 3,337.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
6,869.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ

Production Value: Require guidance or OTC Drug: Other Metabolic Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Other Metabolic Drug data was reported at 36,845,452.000 JPY th in 2020. This records a decrease from the previous number of 43,367,052.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Other Metabolic Drug data is updated yearly, averaging 40,106,252.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 43,367,052.000 JPY th in 2019 and a record low of 36,845,452.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Other Metabolic Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
36,845,452.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Other Metabolic Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Other Metabolic Drug

Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data was reported at 3,557,484.000 JPY th in 2020. This records a decrease from the previous number of 3,696,576.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data is updated yearly, averaging 3,627,030.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 3,696,576.000 JPY th in 2019 and a record low of 3,557,484.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
3,557,484.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose

Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data was reported at 86,271.000 JPY th in 2020. This records an increase from the previous number of 52,301.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data is updated yearly, averaging 69,286.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 86,271.000 JPY th in 2020 and a record low of 52,301.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
86,271.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug

Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data was reported at 696,376.000 JPY th in 2020. This records an increase from the previous number of 645,305.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data is updated yearly, averaging 670,840.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 696,376.000 JPY th in 2020 and a record low of 645,305.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
696,376.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent

Production Value: Require guidance or OTC Drug: Public Health Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Public Health Drug data was reported at 18,136,342.000 JPY th in 2020. This records a decrease from the previous number of 19,253,424.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Public Health Drug data is updated yearly, averaging 18,694,883.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 19,253,424.000 JPY th in 2019 and a record low of 18,136,342.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Public Health Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
18,136,342.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Public Health Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Public Health Drug

Production Value: Require guidance or OTC Drug: Respiratory Organ Agent

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data was reported at 24,790,327.000 JPY th in 2020. This records a decrease from the previous number of 24,975,671.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data is updated yearly, averaging 24,882,999.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 24,975,671.000 JPY th in 2019 and a record low of 24,790,327.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
24,790,327.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Respiratory Organ Agent from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Respiratory Organ Agent

Production Value: Require guidance or OTC Drug: Sensory Organ Agent

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Sensory Organ Agent data was reported at 87,525,864.000 JPY th in 2020. This records a decrease from the previous number of 91,126,757.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Sensory Organ Agent data is updated yearly, averaging 89,326,310.500 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 91,126,757.000 JPY th in 2019 and a record low of 87,525,864.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Sensory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
87,525,864.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Sensory Organ Agent from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Sensory Organ Agent

Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data was reported at 41,107,370.000 JPY th in 2020. This records an increase from the previous number of 38,289,946.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data is updated yearly, averaging 39,698,658.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 41,107,370.000 JPY th in 2020 and a record low of 38,289,946.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
41,107,370.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines

Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data was reported at 8,623,286.000 JPY th in 2020. This records an increase from the previous number of 7,699,150.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data is updated yearly, averaging 8,161,218.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 8,623,286.000 JPY th in 2020 and a record low of 7,699,150.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
8,623,286.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug

Production Value: Require guidance or OTC Drug: Vitamins

2019 - 2020 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Production Value: Require guidance or OTC Drug: Vitamins data was reported at 73,184,214.000 JPY th in 2020. This records a decrease from the previous number of 92,777,770.000 JPY th for 2019. Production Value: Require guidance or OTC Drug: Vitamins data is updated yearly, averaging 82,980,992.000 JPY th from Dec 2019 to 2020, with 2 observations. The data reached an all-time high of 92,777,770.000 JPY th in 2019 and a record low of 73,184,214.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Vitamins data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
73,184,214.000 2020 yearly 2019 - 2020

View Japan's Production Value: Require guidance or OTC Drug: Vitamins from 2019 to 2020 in the chart:

Japan Production Value: Require guidance or OTC Drug: Vitamins
Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use
Production Value: Require guidance or OTC Drug: Allergy Drug
Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug
Production Value: Require guidance or OTC Drug: Cardiovascular Preparation
Production Value: Require guidance or OTC Drug: Cell Activation Drug
Production Value: Require guidance or OTC Drug: Central Nervous System Agent
Production Value: Require guidance or OTC Drug: Chemotherapeutics
Production Value: Require guidance or OTC Drug: Crude Drug
Production Value: Require guidance or OTC Drug: Dermatological Drug
Production Value: Require guidance or OTC Drug: Digestive Organ Agent
Production Value: Require guidance or OTC Drug: Dispensing Drug
Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription
Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic
Production Value: Require guidance or OTC Drug: Hormones, include Antihormones
Production Value: Require guidance or OTC Drug: Nourishing Tonic
Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ
Production Value: Require guidance or OTC Drug: Other Metabolic Drug
Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose
Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug
Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent
Production Value: Require guidance or OTC Drug: Public Health Drug
Production Value: Require guidance or OTC Drug: Respiratory Organ Agent
Production Value: Require guidance or OTC Drug: Sensory Organ Agent
Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines
Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug
Production Value: Require guidance or OTC Drug: Vitamins
Unlimited access tailored to your data needs
Flexible monthly access to CEIC data